Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence
Abstract Background and Aim: The number of longitudinal studies on cognitive functions in patients on buprenorphine-based agonist treatment is limited. Our objective was to assess the change in neurocognitive functions over the first 6 months of buprenorphine-naloxone (BNX) treatment for opioid depe...
Saved in:
Published in | Indian journal of psychiatry Vol. 64; no. 2; pp. 199 - 208 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
India
Medknow Publications & Media Pvt Ltd
01.03.2022
Medknow Publications and Media Pvt. Ltd Medknow Publications & Media Pvt. Ltd Wolters Kluwer - Medknow |
Edition | 2 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!